ADMA BIOLOGICS, INC. 8-K

What Happened

• ADMA Biologics, Inc. filed a Form 8-K on March 2, 2026, disclosing that the company issued a press release on that date. The filing cites Item 7.01 (Regulation FD disclosure) and Item 8.01 (Other Events) and furnishes the press release as Exhibit 99.1, which is incorporated by reference into the 8-K.

Key Details

• Filing date: March 2, 2026 (Form 8-K filed with the SEC).
• Disclosure items: Item 7.01 (Regulation FD) and Item 8.01 (Other Events).
• Exhibit furnished: Exhibit 99.1 — ADMA Biologics press release dated March 2, 2026.
• The cover page interactive data (Inline XBRL) is included as Exhibit 104.

Why It Matters

• The 8-K signals that the company publicly released information on March 2, 2026; investors should read the furnished press release (Exhibit 99.1) to learn any material details disclosed that could affect the company’s outlook or stock price.
• Listing the disclosure under Regulation FD means the company aimed to broadly disseminate the information to all investors at the same time, reducing selective disclosure risk.